Cargando…

Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma

Background: Hepatocellular carcinoma (HCC) is one of the most malignant tumors. The in vitro experiments on the application of Anhydroicaritin (AHI), the active ingredient of Bushen Huayu Decoction, in HCC treatment remain limited, particularly regarding its molecular mechanism. Methods: The TCMSP p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Houhong, Chen, Wenli, Cui, Yayun, Gong, Huihui, Tang, Amao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457047/ https://www.ncbi.nlm.nih.gov/pubmed/37556351 http://dx.doi.org/10.18632/aging.204948

Ejemplares similares

Suppression of AGTR1 Induces Cellular Senescence in Hepatocellular Carcinoma Through Inactivating ERK Signaling
por: Wang, Houhong, et al.
Publicado: (2022)

LRPPRC facilitates tumor progression and immune evasion through upregulation of m(6)A modification of PD-L1 mRNA in hepatocellular carcinoma
por: Wang, Houhong, et al.
Publicado: (2023)

Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway
por: Huang, Lu, et al.
Publicado: (2022)

ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway
por: Ni, Sheng, et al.
Publicado: (2020)

Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”
por: Huang, Lu, et al.
Publicado: (2022)

MDA-19 Suppresses Progression of Melanoma Via Inhibiting the PI3K/Akt Pathway
por: Dang, Ningning, et al.
Publicado: (2018)

Pterostilbene inhibits gallbladder cancer progression by suppressing the PI3K/Akt pathway
por: Tong, Chenhao, et al.
Publicado: (2021)

ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway
por: Cui, Yong, et al.
Publicado: (2022)

Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma
por: Liao, Junbin, et al.
Publicado: (2019)

MicroRNA‐155‐5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway
por: Fu, Xiao, et al.
Publicado: (2017)

LHPP suppresses gastric cancer progression via the PI3K/AKT/mTOR signaling pathway
por: Wang, Danfang, et al.
Publicado: (2022)

Up-Regulation of RACGAP1 Promotes Progressions of Hepatocellular Carcinoma Regulated by GABPA via PI3K/AKT Pathway
por: Gu, Yang, et al.
Publicado: (2022)

STK39 enhances the progression of Cholangiocarcinoma via PI3K/AKT pathway
por: Hao, Xiaopei, et al.
Publicado: (2021)

TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway
por: Ye, Yanqing, et al.
Publicado: (2023)

Hyperoside suppresses BMP-7-dependent PI3K/AKT pathway in human hepatocellular carcinoma cells
por: Wei, Shuang, et al.
Publicado: (2021)

LGALS2 suppresses the progression of papillary thyroid carcinoma by regulating the PI3K/AKT pathway
por: Xu, Debin, et al.
Publicado: (2022)

Salvigenin Suppresses Hepatocellular Carcinoma Glycolysis and Chemoresistance Through Inactivating the PI3K/AKT/GSK-3β Pathway
por: Shao, Hui, et al.
Publicado: (2023)

Propofol suppresses adipose-derived stem cell progression via PI3K/AKT-Wnt signaling pathway
por: Yin, Guoping, et al.
Publicado: (2022)

Glycoprotein M6A Suppresses Lung Adenocarcinoma Progression via Inhibition of the PI3K/AKT Pathway
por: Zhang, Qian, et al.
Publicado: (2022)

Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway
por: Hsieh, Yi-Hsien, et al.
Publicado: (2015)

GBAP1 functions as a tumor promotor in hepatocellular carcinoma via the PI3K/AKT pathway
por: Chen, Rong, et al.
Publicado: (2023)

MARCH1 encourages tumour progression of hepatocellular carcinoma via regulation of PI3K‐AKT‐β‐catenin pathways
por: Xie, Lulu, et al.
Publicado: (2019)

Overexpression of YEATS2 Remodels the Extracellular Matrix to Promote Hepatocellular Carcinoma Progression via the PI3K/AKT Pathway
por: Liu, Xin, et al.
Publicado: (2023)

Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
por: Sun, Eun Jin, et al.
Publicado: (2021)

Silencing of SPP1 Suppresses Progression of Tongue Cancer by Mediating the PI3K/Akt Signaling Pathway
por: Zhang, Qiaoli, et al.
Publicado: (2020)

SMARCC1 Suppresses Tumor Progression by Inhibiting the PI3K/AKT Signaling Pathway in Prostate Cancer
por: Xiao, Zhao-Ming, et al.
Publicado: (2021)

Knockdown of TFRC suppressed the progression of nasopharyngeal carcinoma by downregulating the PI3K/Akt/mTOR pathway
por: Feng, Guofei, et al.
Publicado: (2023)

MicroRNA-10a suppresses breast cancer progression via PI3K/Akt/mTOR pathway
por: Ke, Kongliang, et al.
Publicado: (2017)

Eriodictyol Suppresses Gastric Cancer Cells via Inhibition of PI3K/AKT Pathway
por: Shan, Hui, et al.
Publicado: (2022)

Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells
por: TIAN, FENG, et al.
Publicado: (2015)

Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells
por: Tian, Feng, et al.
Publicado: (2023)

Effect of β-anhydroicaritin on the expression levels of tumor necrosis factor-α and matrix metalloproteinase-3 in periodontal tissue of diabetic rats
por: WU, YINGTAO, et al.
Publicado: (2015)

Anhydroicaritin Inhibits EMT in Breast Cancer by Enhancing GPX1 Expression: A Research Based on Sequencing Technologies and Bioinformatics Analysis
por: Li, Feifei, et al.
Publicado: (2022)

Overexpression of the clock gene Per2 suppresses oral squamous cell carcinoma progression by activating autophagy via the PI3K/AKT/mTOR pathway
por: Liu, Huan, et al.
Publicado: (2020)

Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway
por: Wang, Haiyong, et al.
Publicado: (2016)

Apatinib suppresses the migration, invasion and angiogenesis of hepatocellular carcinoma cells by blocking VEGF and PI3K/AKT signaling pathways
por: Song, Jifu, et al.
Publicado: (2021)

miR-185 suppresses progression of Ewing’s sarcoma via inhibiting the PI3K/AKT and Wnt/β-catenin pathways
por: Zhang, Shuai, et al.
Publicado: (2018)

Knockdown of STIL suppresses the progression of gastric cancer by down‐regulating the IGF‐1/PI3K/AKT pathway
por: Wang, Ju, et al.
Publicado: (2019)

The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
por: Dobbin, Zachary C., et al.
Publicado: (2013)

Research progress on the PI3K/AKT signaling pathway in gynecological cancer
por: Shi, Xiang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fctinvn8umcphau20aj0eucbv8